Eagle Pharmaceuticals saw the highest growth of 0.99% in patent filings and 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Eagle Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Eagle Pharmaceuticals has been focused on protecting inventions in United States(US) with three publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 29% grants. The United States(US), South Korea(KR), Australia(AU), and Israel(IL) patent Office are among the top ten patent offices where Eagle Pharmaceuticals is filings its patents. Among the top granted patent authorities, Eagle Pharmaceuticals has 29% of its grants in United States(US), 29% in Israel(IL) and 14% in South Korea(KR).

Roche and Johnson & Johnson could be the strongest competitors for Eagle Pharmaceuticals

Patents related to climate change and rare diseases lead Eagle Pharmaceuticals's portfolio

Eagle Pharmaceuticals has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 50% of patents were granted in Q2 2024.

Manufacturing/industrial related patents lead Eagle Pharmaceuticals portfolio followed by emesis (vomiting), and post operative nausea and vomiting

Eagle Pharmaceuticals has highest number of patents in manufacturing/industrial followed by emesis (vomiting), post operative nausea and vomiting, nausea. For manufacturing/industrial, nearly 33% of patents were filed and 44% of patents were granted in Q2 2024.

For comprehensive analysis of Eagle Pharmaceuticals's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.